111 related articles for article (PubMed ID: 16434088)
21. In vitro &in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction.
Xiong XY; Guo L; Gong YC; Li ZL; Li YP; Liu ZY; Zhou M
Eur J Pharm Sci; 2012 Aug; 46(5):537-44. PubMed ID: 22538053
[TBL] [Abstract][Full Text] [Related]
22. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic advantage of (90)yttrium- versus (131)iodine-labeled PAM4 antibody in experimental pancreatic cancer.
Cardillo TM; Ying Z; Gold DV
Clin Cancer Res; 2001 Oct; 7(10):3186-92. PubMed ID: 11595713
[TBL] [Abstract][Full Text] [Related]
24. Selection of tumor-specific epitopes on target antigens for radioimmunotherapy of breast cancer.
Peterson JA; Couto JR; Taylor MR; Ceriani RL
Cancer Res; 1995 Dec; 55(23 Suppl):5847s-5851s. PubMed ID: 7493358
[TBL] [Abstract][Full Text] [Related]
25. Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model.
Kelly MP; Lee FT; Smyth FE; Brechbiel MW; Scott AM
J Nucl Med; 2006 Apr; 47(4):716-25. PubMed ID: 16595507
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics, biodistribution, and radioimmunotherapy with monoclonal antibody 776.1 in a murine model of human ovarian cancer.
Berger MA; Masters GR; Singleton J; Scully MS; Grimm LG; Soltis DA; Albone EF
Cancer Biother Radiopharm; 2005 Dec; 20(6):589-602. PubMed ID: 16398611
[TBL] [Abstract][Full Text] [Related]
27. Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.
Press OW; Shan D; Howell-Clark J; Eary J; Appelbaum FR; Matthews D; King DJ; Haines AM; Hamann P; Hinman L; Shochat D; Bernstein ID
Cancer Res; 1996 May; 56(9):2123-9. PubMed ID: 8616860
[TBL] [Abstract][Full Text] [Related]
28. Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis.
Knogler K; Grünberg J; Zimmermann K; Cohrs S; Honer M; Ametamey S; Altevogt P; Fogel M; Schubiger PA; Novak-Hofer I
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):603-11. PubMed ID: 17255283
[TBL] [Abstract][Full Text] [Related]
29. Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression.
DeNardo SJ; Gumerlock PH; Winthrop MD; Mack PC; Chi SG; Lamborn KR; Shen S; Miers LA; deVere White RW; DeNardo GL
Cancer Res; 1995 Dec; 55(23 Suppl):5837s-5841s. PubMed ID: 7493356
[TBL] [Abstract][Full Text] [Related]
30. 211At radioimmunotherapy of subcutaneous human ovarian cancer xenografts: evaluation of relative biologic effectiveness of an alpha-emitter in vivo.
Bäck T; Andersson H; Divgi CR; Hultborn R; Jensen H; Lindegren S; Palm S; Jacobsson L
J Nucl Med; 2005 Dec; 46(12):2061-7. PubMed ID: 16330571
[TBL] [Abstract][Full Text] [Related]
31. Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6.
O'Donnell RT; DeNardo SJ; Miers LA; Lamborn KR; Kukis DL; DeNardo GL; Meyers FJ
Prostate; 2002 Jan; 50(1):27-37. PubMed ID: 11757033
[TBL] [Abstract][Full Text] [Related]
32. Radioimmunotherapy with 90Y-labeled monoclonal antibodies in a nude mouse ovarian cancer model.
Kairemo K; Ljunggren K; Strand SE; Hiltunen J; Penttilä P; Nikula T; Laine A; Wahlström T
Acta Oncol; 1993; 32(7-8):801-5. PubMed ID: 8305229
[TBL] [Abstract][Full Text] [Related]
33. Advantage of yttrium-90-labeled over iodine-131-labeled monoclonal antibodies in the treatment of a human lung carcinoma xenograft.
Stein R; Chen S; Haim S; Goldenberg DM
Cancer; 1997 Dec; 80(12 Suppl):2636-41. PubMed ID: 9406718
[TBL] [Abstract][Full Text] [Related]
34. Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancer.
Guo Y; Nemeth J; O'Brien C; Susa M; Liu X; Zhang Z; Choy E; Mankin H; Hornicek F; Duan Z
Clin Cancer Res; 2010 Dec; 16(23):5759-69. PubMed ID: 20699329
[TBL] [Abstract][Full Text] [Related]
35. Human anti-mouse IgM and IgG responses in ovarian cancer patients after radioimmunotherapy with 90Y-muHMFG1.
Oei AL; Sweep FC; Geurts-Moespot A; van Tienoven D; Von Mensdorff-Pouilly S; Thomas CM; Massuger LF
Anticancer Res; 2008; 28(5A):2721-5. PubMed ID: 19035301
[TBL] [Abstract][Full Text] [Related]
36. Radioimmunotherapy of pancreatic cancer xenografts in nude mice using 90Y-labeled anti-α6β4 integrin antibody.
Aung W; Tsuji AB; Sudo H; Sugyo A; Ukai Y; Kouda K; Kurosawa Y; Furukawa T; Saga T
Oncotarget; 2016 Jun; 7(25):38835-38844. PubMed ID: 27246980
[TBL] [Abstract][Full Text] [Related]
37. Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
Kosmas C; Snook D; Gooden CS; Courtenay-Luck NS; McCall MJ; Meares CF; Epenetos AA
Cancer Res; 1992 Feb; 52(4):904-11. PubMed ID: 1737353
[TBL] [Abstract][Full Text] [Related]
38. Preclinical assessment of 90Y-labeled monoclonal antibody CO17-1A, a potential agent for radioimmunotherapy of colorectal carcinoma.
Washburn LC; Lee YC; Sun TT; Byrd B; Crook JE; Stabin MG; Steplewski Z
Int J Rad Appl Instrum B; 1988; 15(6):707-11. PubMed ID: 3251904
[TBL] [Abstract][Full Text] [Related]
39. Intraperitoneal radioimmunotherapy in an ovarian carcinoma mouse model: Effect of the radionuclide.
Janssen ML; Pels W; Massuger LF; Oyen WJ; Boonstra H; Corstens FH; Boerman OC
Int J Gynecol Cancer; 2003; 13(5):607-13. PubMed ID: 14675343
[TBL] [Abstract][Full Text] [Related]
40. Intraperitoneal radioimmunotherapy with human monoclonal IGM in nude mice with peritoneal carcinomatosis.
Borchardt PE; Quadri SM; Freedman RS; Vriesendorp HM
Cancer Biother Radiopharm; 2000 Feb; 15(1):53-64. PubMed ID: 10740653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
